Whole-body-MR imaging including DWIBS in the work-up of patients with head and neck squamous cell carcinoma: A feasibility study

European Journal of Radiology

Volumn 83, Issue 7, 2014, Pages 1144-1151

  Noij, Daniel P ^a   Boerhout, Els J ^a   Pieters Van Den Bos, Indra C ^a   Comans, Emile F ^a   Oprea Lager, Daniela ^a   Reinhard, Rinze ^a   Hoekstra, Otto S ^a   De Bree, Remco ^a   De Graaf, Pim ^a   Castelijns, Jonas A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diffusion magnetic resonance imaging; Feasibility studies; Head and neck neoplasms; Positron emission tomography; Second primary neoplasms

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOBUTROL; GADOTERATE MEGLUMINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEASIBILITY STUDY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HYPOPHARYNX CARCINOMA; IMAGE QUALITY; LARYNX CARCINOMA; METASTASIS; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SECOND CANCER; WHOLE BODY IMAGING; WHOLE BODY IMAGING WITH BACKGROUND BODY SIGNAL SUPPRESSION; WHOLE BODY MRI; CARCINOMA, SQUAMOUS CELL; COMPARATIVE STUDY; DIAGNOSTIC USE; DIFFUSION WEIGHTED IMAGING; EVALUATION STUDY; FEMALE; HEAD AND NECK NEOPLASMS; MALE; MULTIMODAL IMAGING; OBSERVER VARIATION; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AGED; CARCINOMA, SQUAMOUS CELL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OBSERVER VARIATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 84902255271     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2014.03.019     Document Type: Article

References (28)

1. R. de Bree, M. Haigentz, C.E. Silver, D. Paccagnella, M. Hamoir, and D.M. Hartl et al. Distant metastases from head and neck squamous cell carcinoma. Part II. Diagnosis Oral Oncol 48 9 2012 780 786
2. A. Senft, R. de Bree, O.S. Hoekstra, D.J. Kuik, R.P. Golding, and W.J. Oyen et al. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial Radiother Oncol 87 2 2008 221 229
3. S.H. Ng, S.C. Chan, C.T. Liao, J.T. Chang, S.F. Ko, and H.M. Wang et al. Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT Neuroradiology 50 11 2008 969 979
4. S.Y. Kim, J.L. Roh, N.K. Yeo, J.S. Kim, J.H. Lee, and S.H. Choi et al. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer Ann Oncol 18 10 2007 1698 1703
5. R. de Bree, E.E. Deurloo, G.B. Snow, and C.R. Leemans Screening for distant metastases in patients with head and neck cancer Laryngoscope 110 3 Pt 1 2000 397 401
6. J. Fruehwald-Pallamar, C. Czerny, M.E. Mayerhoefer, B.S. Halpern, C. Eder-Czembirek, and Brunner et al. Functional imaging in head and neck squamous cell carcinoma: correlation of PET/CT and diffusion-weighted imaging at 3 T Eur J Nucl Med Mol Imaging 38 6 2011 1009 1019
7. S.C. Chan, H.M. Wang, T.C. Yen, C.Y. Lin, S.C. Chin, and C.T. Liao et al. 18F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/ hypopharyngeal carcinoma: a comparative study Eur J Nucl Med Mol Imaging 38 9 2011 1607 1619
8. S.H. Ng, S.C. Chan, T.C. Yen, J.T. Chang, C.T. Liao, and S.F. Ko et al. Pretreatment evaluation of distant-site status in patients with nasopharyngeal carcinoma: accuracy of whole-body MRI at 3-T and FDG-PET-CT Eur Radiol 19 12 2009 2965 2976
9. T. Takahara, Y. Imai, T. Yamashita, S. Yasuda, S. Nasu, and M. Van Cauteren Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display Radiat Med 22 4 2004 275 282
10. P. Mürtz, C. Krautmacher, F. Träber, J. Gieseke, H.H. Schild, and W.A. Willinek Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 T Eur Radiol 17 12 2007 3031 3037
11. T. Komori, I. Narabayashi, K. Matsumura, M. Matsuki, H. Akagi, and Y. Ogura et al. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience Ann Nucl Med 21 4 2007 209 215
12. G. Sommer, M. Klarhöfer, C. Lenz, K. Scheffler, G. Bongartz, and L. Winter Signal characteristics of focal bone marrow lesions in patients with multiple myeloma using whole body T1w-TSE, T2w-STIR and diffusion-weighted imaging with background suppression Eur Radiol 21 4 2011 857 862
13. G.P. Schmidt, A. Baur-Melnyk, A. Haug, V. Heinemann, I. Bauerfeind, and M.F. Reiser et al. Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT Eur J Radiol 65 1 2008 47 58
14. G.P. Schmidt, A. Baur-Melnyk, A. Haug, S. Utzschneider, C.R. Becker, and R. Tiling et al. Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer Eur Radiol 19 6 2009 1366 1378
15. M.A. Fischer, D. Nanz, T. Hany, C.S. Reiner, P. Stolzmann, and O.F. Donati et al. Diagnostic accuracy of whole-body MRI/DWI image fusion for detection of malignant tumours: a comparison with PET/CT Eur Radiol 21 2 2011 246 255
16. T.A. Heusner, S. Kuemmel, A. Koeninger, M.E. Hamami, S. Hahn, and A. Quinsten et al. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging Eur J Nucl Med Mol Imaging 37 6 2010 1077 1086
17. K. Brauck, M.O. Zenge, F.M. Vogt, H.H. Quick, F. Stock, and T. Trarbach et al. Feasibility of whole-body MR with T2- and T1-weighted real-time steady-state free precession sequences during continuous table movement to depict metastases Radiology 246 3 2008 910 916
18. Y. Ohno, H. Koyama, Y. Onishi, D. Takenaka, M. Nogami, and T. Yoshikawa et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT Radiology 248 2 2008 643 654
19. H.C. de Vet, L.B. Mokkink, C.B. Terwee, O.S. Hoekstra, and D.L. Knol Clinicians are right not to like Cohen's κ BMJ 346 2013 f2125
20. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1 1977 159 174
21. T.C. Kwee, T. Takahara, R. Ochiai, R.A. Nievelstein, and P.R. Luijten Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology Eur Radiol 18 9 2008 1937 1952
22. L.G. Morris, A.G. Sikora, S.G. Patel, R.B. Hayes, and I. Ganly Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer J Clin Oncol 29 6 2011 739 746
23. N. Oyama, H. Ito, N. Takahara, Y. Miwa, H. Akino, and T. Kudo et al. Diagnosis of complex renal cystic masses and solid renal lesions using PET imaging: comparison of 11C-acetate and 18F-FDG PET imaging Clin Nucl Med 39 3 2014 e208 e214
24. H. Jadvar Hepatocellular carcinoma and gastroenteropancreatic neuroendocrine tumors: potential role of other positron emission tomography radiotracers Semin Nucl Med 42 4 2012 247 254
25. S.H. Ng, S.C. Chan, T.C. Yen, C.T. Liao, C.Y. Lin, and J. Tung-Chieh Chang et al. PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma Eur J Nucl Med Mol Imaging 38 6 2011 996 1008
26. C. Plathow, M. Walz, M.P. Lichy, P. Aschoff, C. Pfannenberg, and H. Bock et al. Cost considerations for whole-body MRI and PET/CT as part of oncologic staging Radiologe 48 4 2008 384 396
27. H.M. Quarles van Ufford, H. van Tinteren, S.G. Stroobants, I.I. Riphagen, and O.S. Hoekstra Added value of baseline 18F-FDG uptake in serial 18F-FDG PET for evaluation of response of solid extracerebral tumors to systemic cytotoxic neoadjuvant treatment: a meta-analysis J Nucl Med 51 10 2010 1507 1516
28. A. Padhani, and D. Koh Whole-body diffusion-weighted MR imaging in cancer: current status and research directions Radiology 261 3 2011 700 718